US Patent Issued to Viking Therapeutics on Sept. 23 for "Compositions and methods for the treatment of metabolic and liver disorders" (California Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,282, issued on Sept. 23, was assigned to Viking Therapeutics Inc. (San Diego).

"Compositions and methods for the treatment of metabolic and liver disorders" was invented by Brian Lian (Rancho Santa Fe, Calif.), Geoffrey E. Barker (Carlsbad, Calif.), Kader Yagiz (San Diego), Maureen Barnes (San Diego) and Erland Stevens (Davidson, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are small molecule GIP/GLP-1 dual receptor agonist compositions, pharmaceutical compositions, the use and preparation thereof."

The patent was filed on Sept. 12, 2022, under Application No. 18/274,952.

*For further information, including images, chart...